GlassScriptPhysician profile
Alexandra Sanchez
NPI 1073041174
$69,056.39
in general payments reported to CMS, 2019-2025
27 companies · $9,247 in 2025
The $9,247 reported for 2025 was more than what 94% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $251 · 2020: $449 · 2021: $3,000 · 2022: $3,854 · 2023: $28K · 2024: $24K · 2025: $9,247.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $41K · Food and Beverage: $11K · Travel and Lodging: $8,552 · Education: $497.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $41,250.00 |
| Food and Beverage | $11,203.09 |
| Travel and Lodging | $8,552.38 |
| Education | $496.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $31,713.79 | 2023-2025 | Ensite Precision, Ensite, Gallant |
| Medtronic, INC. | $19,764.63 | 2021-2025 | Micra, Aurora Ev-Icd Mri Surescan, Corevalve Evolut R |
| Biotronik INC. | $5,552.44 | 2021-2023 | Acticor 7 Vr-T Dx |
| Boston Scientific Corporation | $4,839.16 | 2021-2025 | Watchman Access System, S-Icd System Magnet |
| Philips North America LLC | $1,129.60 | 2025 | Igt Devices Undivided, Lm Undivided |
| Amgen INC. | $1,041.31 | 2021-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $719.58 | 2020-2024 | Farxiga |
| Novo Nordisk INC | $709.75 | 2022-2025 | Ozempic |
| Pfizer INC. | $523.49 | 2020-2025 | |
| E.R. Squibb & Sons, L.L.C. | $472.87 | 2020-2024 | Camzyos |
| Biosense Webster, INC. | $449.03 | 2024-2025 | Carto 3, Qdot Micro, Qdot Micro Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $445.74 | 2024-2025 | Lifevest |
| Astellas Pharma US INC | $251.88 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $194.78 | 2019-2024 | Jardiance |
| Becton, Dickinson and Company | $191.39 | 2025 | Hemosphere |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $169.12 | 2022 | |
| Inari Medical, INC. | $146.42 | 2021-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Kestra Medical Technology Services, INC. | $138.64 | 2024-2025 | Assure Wcd |
| Lantheus Medical Imaging, INC. | $137.01 | 2021-2022 | |
| Edwards Lifesciences Corporation | $125.00 | 2019 | |
| Esperion Therapeutics, INC. | $112.42 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $67.23 | 2024 | Xarelto |
| Shockwave Medical, INC | $43.16 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cardiva Medical, INC. | $42.33 | 2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Lexicon Pharmaceuticals, INC. | $28.08 | 2024 | |
| Merck Sharp & Dohme LLC | $25.48 | 2025 | Verquvo |
| Livanova USA, INC. | $22.06 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexandra Sanchez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.